Sunovion Pharmaceuticals. - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Sunovion Pharmaceuticals. M&A Summary

Sunovion Pharmaceuticals. has acquired 2 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Sunovion Pharmaceuticals.’s largest acquisition to date was in 2016, when it acquired Cynapsus Therapeutics for $624M. It’s largest disclosed sale occurred in 2014, when it sold Xopenex Inhalation Solution to Akorn for $45M. Sunovion Pharmaceuticals. has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Sunovion Pharmaceuticals. Ownership

Who owns Sunovion Pharmaceuticals.?

Sunovion Pharmaceuticals. is owned by Sumitomo Pharma. It was acquired on September 3, 2009.

Sunovion Pharmaceuticals. Business Overview

Where is Sunovion Pharmaceuticals. headquartered?

Sunovion Pharmaceuticals. is headquartered in Marlborough, Massachusetts.

How many employees does Sunovion Pharmaceuticals. have?

Sunovion Pharmaceuticals. has 2,100 employees.

What sector is Sunovion Pharmaceuticals. in?

Sunovion Pharmaceuticals. is a life science company.

When was Sunovion Pharmaceuticals. founded?

Sunovion Pharmaceuticals. was founded in 1984.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity2
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3
  • M&A Advisors 5

Sunovion Pharmaceuticals. Inc.

84 Waterford Drive,
Marlborough, Massachusetts 01752
United States,
(508) 481-6700
www.sunovion.com

Sunovion is a pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the central nervous system (CNS) and respiratory disease areas and improve the lives of patients and their families.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $1.1B $1.1B
Sell (0.2/yr) # 1 - 1 - - - 2
vol $45M $45M
  4

Most Recent M&A

Company Date Value Type
CNX Therapeutics Ltd. 2021-08-19 - Divestiture
London, United Kingdom · www.cnx-therapeutics.com
Cynapsus Therapeutics, Inc. 2016-08-31 624M USD Add-on Acquisition
Toronto, Ontario · www.cynapsus.ca
Xopenex Inhalation Solution 2014-09-30 45M USD Divestiture
, United States
Elevation Pharmaceuticals 2012-09-05 430M USD Add-on Acquisition
San Diego, California · www.elevationpharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 1.1B (100%) 1 (50%) -
Medical Products - - 1 (50%) 45M (100%)
Total 2 $1.1B 2 $45M

By Geo

State/Country Buy Value Sell Value
United States 1 430M 1 45M
  California 1 430M - -
Canada 1 624M - -
  Ontario 1 624M - -
United Kingdom - - 1 -
Domestic 1 (50%) 430M (41%) 1 (50%) 45M (100%)
Cross-border 1 (50%) 624M (59%) 1 (50%) -
Total 2 $1.1B 2 $45M

Top M&A Advisors

Financial Deals
Nomura Investment Bank
 1
Barclays Investment Bank
 1
Legal Deals
Goodmans
 1
Gibbons
 1
Reed Smith
 1

Deal Values

buy # Total
$100M to $1B 2 $1.1B
TOTAL $1.1B
Largest Cynapsus Therapeutics, Inc.
$624M (2016-08-31)
sell # Total
< $100M 1 $45M
TOTAL $45M
Largest Xopenex Inhalation Solution
$45M (2014-09-30)

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)
Divested to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

Company Summary

SECTOR

Life Science

Revenue

1,292   2008
(millions of USD)

Employees

2,100

Established

1984

Former Name

Sepracor, Inc.

 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Sunovion Pharmaceuticals.

Massachusetts Companies , Life Science Companies , United States Companies , Massachusetts Life Science Companies , Massachusetts Life Science with Acquisitions , Massachusetts Life Science with Divestitures

Related Lists for Massachusetts Companies

Largest Massachusetts Companies , Acquisitive Massachusetts Companies , Recently Acquired Massachusetts Companies , Recently Sold Massachusetts Companies , Private Massachusetts Companies , Public Massachusetts Companies , Acquired Massachusetts Companies , PE Backed Massachusetts Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal